SavedAdd your journal

Journals / Journal of Basic and Clinical Health Sciences / 2026 / Volume: 6 Issue: 3

The Relationship between Fear of Covid-19, Anxiety and Depression in Pregnant Women

Ayşe Akalın(DUZCE UNIVERSITY)0000-0002-9575-7537
Fatma Ayhan(BATMAN UNIVERSITY)0000-0001-9717-1727
Gökhan Göynümer(DUZCE UNIVERSITY)0000-0002-3739-6008
Pages
—
Publication Date
2022-09-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, 14.0% of pregnant women had depression risk and 42.4% had symptoms of anxiety (26.3% low level, 10.4% moderate level and 5.7% high level).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of the study was to investigate the relationship between coronavirus disease-19 (COVID-19) fear, anxiety and depression on pregnant women.
📊
Key Findings & Data:Methods: The cross-sectional, correlational research was conducted with 335 pregnant women from June to October 2020 at the antenatal outpatient clinics of a university hospital.
💡
Conclusion & Impact:Overall, 14.0% of pregnant women had depression risk and 42.4% had symptoms of anxiety (26.3% low level, 10.4% moderate level and 5.7% high level).
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · fear · depression

Abstract

Purpose: The aim of the study was to investigate the relationship between coronavirus disease-19 (COVID-19) fear, anxiety and depression on pregnant women. Methods: The cross-sectional, correlational research was conducted with 335 pregnant women from June to October 2020 at the antenatal outpatient clinics of a university hospital. Data were collected using Description Form, Fear of COVID-19 Scale (FCV-19S), Beck Anxiety Inventory (BAI) and the Edinburgh Postnatal Depression Scale (EPDS). Results: The FCV-19S, BAI and EPDS average scores were 21.12±6.56, 6.39±5.48 and 8.13±9.13, respectively, indicating pregnant women' levels of COVID-19 fear were moderately high and their anxiety and depression levels were moderate. Overall, 14.0% of pregnant women had depression risk and 42.4% had symptoms of anxiety (26.3% low level, 10.4% moderate level and 5.7% high level). A positive, significant relationship was found between the COVID-19 fear level and depression (r=0.207, p<0.001), and anxiety level (r=0.135, p<0.013). COVID-19 fear and anxiety significantly predicted the risk of depression (β=0.17, p<0.001; β=0.43, p<0.001) and they explain 24% of the variance in depression. Conclusion: The level of COVID-19 fear increased anxiety and depression risk in pregnant women. In this context, it seems that using effective interventions to decrease of COVID-19 fear may help in reducing anxiety and risk of depression among pregnant women.

🔖

Cite This Article

Akalın, A., Ayhan, F., Göynümer, G., *, A. A. (2022). The Relationship between Fear of Covid-19, Anxiety and Depression in Pregnant Women. Journal of Basic and Clinical Health Sciences, Volume: 6 Issue: 3. https://doi.org/10.30621/jbachs.1040196

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (35)

  1. WHO. Coronavirus disease (Covid‐19) pandemic (2020). Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov
  2. WHO. Coronavirus Disease (COVID-19) Dashboard. Accessed Date: 18.10.2021. Available from: https://covid19.who.int/ Republic of Turkey Ministry. COVID-19 Information Page. Accessed Date: 18.10.2021. Available from: https://covid19.saglik.gov.tr
  3. ACOG. Novel coronavirus 2019 (COVID-19). Practice advisory 2020. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019
  4. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320.
  5. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong V, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status-United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69(44):1641-1647.
  6. Schwatz D, Grahan A. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020;12(2):194.
  7. Bayrampour H, Salmon C, Vinturache A, Tough S. Effect of depressive and anxiety symptoms during pregnancy on risk of obstetric interventions. J Obstet Gynaecol Res 2015;41(7):1040–1048.
  8. Qiao Y, Wang J, Li J, Wang J. Effects of depressive and anxiety symptoms during pregnancy on pregnant, obstetric and neonatal outcomes: a follow-up study. J Obstet Gynaecol 2012;32:237–240.
  9. Ravaldi C, Wilson A, Ricca V, Homer C, Vannacci A. Pregnant women voice their concerns and birth expectations during the COVID-19 pandemic in Italy. Women Birth. 2021;34:335-343.
  10. Durankuş F, Aksu E. Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: a preliminary study. J Matern Fetal Neonatal Med 2020;1-7. doi: 10.1080/14767058.2020.1763946
  11. Sut HK. Kucukkaya B. Anxiety, depression, and related factors in pregnant women during the COVID‐19 pandemic in Turkey: A web‐based cross‐sectional study. Perspectives in Psychiatric Care 2021;57:860-868.
  12. Lebel C, MacKinnon A, Bagshawe M, Tomfohr-Madsen L, Giesbrecht G. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. J Affect Disord 2021;277:5-13.
  13. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 2020; 1-9. https://doi.org/10.1007/s11469-020-00270-8
  14. Satici B, Gocet-Tekin E, Deniz ME, Satici SA. Adaptation of the fear of COVID-19 Scale: Its association with psychological distress and life satisfaction in Turkey. Int J Ment Health Addict 2020;1-9. https://doi.org/10.1007/s11469-020-00294-0
  15. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893-897. Ulusoy M, Şahin N, Erkman H. Turkish version of The Beck anxiety inventory: Psychometric properties. J Cogn Psychother 1998;12:28-35.
  16. Cox JL, Holden JM, Sagovsky R. Detection of postpartum depression. Development of the 10-item edinburg postpartum depression scale. Brit J Psychiatry 1987;150:782–786.
  17. Murray D, Cox JL. Screening for depression during pregnancy with the edinburgh depression scale (EPDS). J Repro Infant Psychol 1990;8:99-107.
  18. Engindeniz AN, Küey L, Kültür S. Edinburgh Depression Scale postpartum validity and reliability of Turkish form. Psychiatric Assoc Pub 1997;1:51–52.
  19. Akalin A, Ayhan F, Goynumer FG. COVID-19 fear and depression in postpartum women during the COVID‐19 pandemic. J Basic Clin Health Sci 2021;(special issue)5:813-826.
  20. Tokgoz VY, Kaya Y, Basar Tekin A. The level of anxiety in infertile women whose ART cycles are postponed due to the COVID-19 outbreak. J Psychosom Obstet Gynaecol 2020. DOI: 10.1080/0167482X.2020.1806819
  21. Anikwe CC, Ogah CO, Anikwe IH, Okorochukwu BC, Ikeoha CC. Coronavirus disease 2019: Knowledge, attitude, and practice of pregnant women in a tertiary hospital in Abakaliki, southeast Nigeria. Int J Gynecol Obstet 2020;151:197–202.
  22. Taubman O, Ari B, Chasson M, Sharkia AS, Weiss E. Distress and anxiety associated with COVID-19 among Jewish and Arab pregnant women in Israel. J Reprod Infant Psychol 2020;38:340-348.
  23. RCOG. Guidance for antenatal and postnatal services in the evolving coronavirus (COVID-19) pandemic 2020. Available from: https://www.rcog.org.uk/coronavirus-pregnancy
  24. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292-297.
  25. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458.
  26. Gottfredsson M. The Spanish flu in Iceland 1918. Lessons in medicine and history. Laeknabladid 2008;94:737–745 (in Icelandic).
  27. Sahoo S, Pattnaik JI, Mehra A, Nehra R, Padhy SK, Grover S. Beliefs related to sexual intimacy, pregnancy and breastfeeding in the public during COVID-19 era: a web-based survey from India. J Psychosom Obstet Gynaecol 2021;42:100-107.
  28. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395:809-815.
  29. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020;99:823–829.
  30. Wu Y, Zhang C, Liu H, Duan C, Li C, Fan J, et al. Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China. Am J Obstet Gynecol 2020;223: 240.e1-240.e9.
  31. Davenport MH, Meyer S, Meah VL, Strynadka MC, Khurana R. Moms are not ok: COVID-19 and maternal mental health. Front women's health 2020;1(1):1-6. doi.org/10.3389/fgwh.2020.00001
  32. Liu X, Chen M, Wang Y, Sun L, Zhang J, Shi Y, et al. Prenatal anxiety and obstetric decisions among pregnant women in Wuhan and Chongqing during the COVID-19 outbreak: a cross-sectional study. BJOG 2020;127:1229–1240.
  33. ACOG. ACOG Committee Opinion. Screening for Perinatal Depression. Obstet Gynecol. 2018;132(5):e208-e212.
  34. Saccone G, Florio A, Aiello F, Venturella R, De Angelis MC, Locci M, et al. Psychological Impact of COVID-19 in pregnant women. Am J Obstet Gynecol 2020;223(2):293-295. doi: 10.1016/j.ajog.2020.05.003.
  35. Fakari FR, Simbar M. Coronavirus pandemic and worries during pregnancy; a letter to editor. Arch Acad Emerg Med 2020;8(1).e21.